Post job

Spark Therapeutics CEO and executives

Executive Summary. Based on our data team's research, Jeffrey D. Marrazzo is the Spark Therapeutics's CEO. Spark Therapeutics has 368 employees, of which 21 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Spark Therapeutics executive team is 38% female and 62% male.
  • 57% of the management team is White.
  • 17% of Spark Therapeutics management is Hispanic or Latino.
  • 9% of the management team is Black or African American.
Work at Spark Therapeutics?
Share your experience

Rate Spark Therapeutics' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Jeffrey D. Marrazzo

Chief Executive Officer, Co-Founder

Jeffrey D. Marrazzo's LinkedIn

Jeff Marrazzo founded and has led the growth of Spark Therapeutics from a research center within the Children’s Hospital of Philadelphia to a fully integrated, commercial gene therapy company that is challenging the inevitability of genetic disease by discovering, developing and delivering potential treatments in ways unimaginable - until now.

Under Jeff’s leadership, Spark has developed and commercialized the first gene therapy for a genetic disease in the United States while proving its technology for the delivery of genes as a medicine to both the eye and liver. In less than seven years, Jeff has built an organization of more than 450 colleagues while securing over $1 billion in capital and successfully orchestrating a merger with Roche.

Jeff currently serves as a board member of Life Science Cares Philadelphia and The Rendell Center for Civics and Civic Engagement. Jeff received a B.A. in economics and B.S.E. in systems science and engineering from the University of Pennsylvania. He also holds a dual M.B.A. / M.P.A. from The Wharton School of the University of Pennsylvania and Harvard University, a program which he founded.

Jeff can be found on Twitter @JeffMarrazzo.

Katherine A. High

Founder

J. Wright

Founder

Cynthia Pussinen

Chief Technical Officer

Cynthia Pussinen's LinkedIn

Cynthia Pussinen is an Exec VP:Technical Ops & Supply Chain at ACTINIUM PHARMACEUTICALS, INC. and Chief Technical Officer at SPARK THERAPEUTICS, INC. and is based in New York, New York. She has worked as Head:Strategic Portfolio Management at Pfizer SAS., Global Head:Supply Chain Logistics at Pfizer SAS., and Senior Director (Development Project Director) at IPSEN. Cynthia works or has worked as Principal/CEO; Life Sciences Executive Specializing in Technical Operations and Business Operations at FinnVictus Strategic Consulting, Event Volunteer at WEST - Women in the Enterprise of Science and Technology, and Mentor at Strategic Operations Inc. She studied at Thames Valley State Technical College, MIT, and Rensselaer Polytechnic Institute between 1997 and 2001.

Federico Mingozzi

Chief Scientific Officer

Federico Mingozzi's LinkedIn

Federico Mingozzi is a Chief Scientific Officer at SPARK THERAPEUTICS, INC. and Research Director 2 (DR2) at INSERM and is based in Greater Philadelphia Area. He has worked as Associate Professor at Université Pierre et Marie Curie – UPMC (Paris 6), Research Associate at Children's Hospital of Philadelphia, and Head of the Immunology and Liver Gene Transfer Unit at Genethon. Federico studied at University of Ferrara between 1993 and 1998, Drexel University between 2005 and 2006, and University of Ferrara between 2001 and 2003.

Joseph W. la Barge

Chief Legal Officer

Joseph W. la Barge's LinkedIn

Senior executive with broad set of experiences and track record of executing business strategies in corporate finance, business development, legal and compliance, and intellectual property. Executive with demonstrated ability to balance business objectives and legal risk.

Lisa Dalton

Chief People Officer

Lisa Dalton's LinkedIn

Lisa Dalton is a Chief People Officer at SPARK THERAPEUTICS, INC. and is based in Philadelphia, Pennsylvania. She has worked as Chief Human Resources Officer at SPARK THERAPEUTICS, INC.; Head:HR at SPARK THERAPEUTICS, INC.; and SR. COMPENSATION CONSULTANT at Shire. Lisa attended Rutgers Graduate Business School between 1996 and 1998, Penn State University between 1991 and 1995, and Rutgers Business School between 1996 and 1998.

Robert J. Perez

Board Member

Spark Therapeutics

Board Member

Spark Therapeutics's LinkedIn

Bruce Resnick

Board Member

Do you work at Spark Therapeutics?

Does leadership effectively guide Spark Therapeutics toward its goals?

Spark Therapeutics jobs

Spark Therapeutics founders

Name & TitleBio
Jeffrey D. Marrazzo

Chief Executive Officer, Co-Founder

Jeffrey D. Marrazzo's LinkedIn

Jeff Marrazzo founded and has led the growth of Spark Therapeutics from a research center within the Children’s Hospital of Philadelphia to a fully integrated, commercial gene therapy company that is challenging the inevitability of genetic disease by discovering, developing and delivering potential treatments in ways unimaginable - until now.

Under Jeff’s leadership, Spark has developed and commercialized the first gene therapy for a genetic disease in the United States while proving its technology for the delivery of genes as a medicine to both the eye and liver. In less than seven years, Jeff has built an organization of more than 450 colleagues while securing over $1 billion in capital and successfully orchestrating a merger with Roche.

Jeff currently serves as a board member of Life Science Cares Philadelphia and The Rendell Center for Civics and Civic Engagement. Jeff received a B.A. in economics and B.S.E. in systems science and engineering from the University of Pennsylvania. He also holds a dual M.B.A. / M.P.A. from The Wharton School of the University of Pennsylvania and Harvard University, a program which he founded.

Jeff can be found on Twitter @JeffMarrazzo.

Katherine A. High

Founder

J. Wright

Founder

Spark Therapeutics board members

Name & TitleBio
Robert J. Perez

Board Member

Spark Therapeutics

Board Member

Spark Therapeutics's LinkedIn

Bruce Resnick

Board Member

Elliott Sigal

Board Member

Lota Zoth

Board Member

Sean A. Johnston

Board Member

Anand Mehra

Board Member

Lars Ekman

Board Member

What employees say about the executives at Spark Therapeutics

Employee reviews
profile
5.0
A zippia user wrote a review on Jul 2022
Pros of working at Spark Therapeutics

Amazing corporate culture, great work-life balance, wonderful people

Cons of working at Spark Therapeutics

Limited growth opportunities

Spark Therapeutics benefits

Long term stock

Is this useful?
Work at Spark Therapeutics? Share your experience

Spark Therapeutics executives FAQs

Zippia gives an in-depth look into the details of Spark Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Spark Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Spark Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Spark Therapeutics. The data presented on this page does not represent the view of Spark Therapeutics and its employees or that of Zippia.

Spark Therapeutics may also be known as or be related to SPARK THERAPEUTICS INC, Spark Therapeutics, Spark Therapeutics Inc and Spark Therapeutics, Inc.